HEALTH CARE RESOURCE USE (HCRU) DUE TO BLEEDING RELATED EPISODES (BRE) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP) RECEIVING ELTROMBOPAG (EPAG), ROMIPLOSTIM (ROMI), OR RITUXIMAB (RITUX): REAL WORLD EVIDENCE (RWE) FROM 27 US INSTITUTIONS-MedSci.cn

HEALTH CARE RESOURCE USE (HCRU) DUE TO BLEEDING RELATED EPISODES (BRE) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP) RECEIVING ELTROMBOPAG (EPAG), ROMIPLOSTIM (ROMI), OR RITUXIMAB (RITUX): REAL WORLD EVIDENCE (RWE) FROM 27 US INSTITUTIONS

Kwon, C; Forsythe, A; Roy, A; Bhor, M; Portella, MSO; Tremblay, G

VALUE IN HEALTH, 2017; 20 (9): A558

科室
- - 订阅+
  - 更多科室
工具
服务